Patrick M. Fisher, Ph.D.

Graduated: December, 2010
Mentor: Dr. Julie Price
Thesis: In vivo assessment of serotonergic signaling pathways underlying the corticolimbic response to threat in humans
Current Position: Postdoctoral fellow Center for Integrated Molecular Brain Imaging, Neurobiology Research Unit, Copenhagen, Denmark
Prior Degree: BS Carnegie Mellon University (2004)


Fisher, P.M., Meltzer, C.C., Price, J.C., Coleman, R.L., Ziolko, S.K., Becker, C., Moses-Kolko, E.L., Berga, S.L. and Hariri, A.R. Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cerebral Cortex, 19(11): 2499-2507, 2009.

Forbes, E.E., Hariri, A.R., Martin, S.L., Silk, J.S., Moyles, D.L., Fisher, P.M., Brown, S.M., Ryan, N.D., Birmaher, B., Axelson, D.A. and Dahl, R.E. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. American Journal of Psychiatry, 166(1): 64-73, 2009.

Fakra, E., Hyde, L.W., Gorka, A., Fisher, P.M., Munoz, K.E., Kimak, M., Halder, I., Ferrell, R.E., Manuck, S.B. and Hariri, A.R. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Archives of General Psychiatry, 2009 Jan; 66(1): 33-40.

Bigos, K.L., Pollock, B.G., Aizenstein, H.J., Fisher, P.M., Bies, R.R. and Hariri, A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology, 2008 Dec; 33(13): 3221-5. Epub 2008 May 7.

Fisher, P.M., Munoz, K.E. and Hariri, A.R. Identification of neurogenetic pathways of risk for psychopathology. Am J Med Genet C Semin Med Genet, 2008 May 15;148(2): 147-53, 2008. Review.

Hariri, A.R. and Fisher, P.M. 5-HT1A autoreceptor regulation of corticolimbic reactivity in the pathophysiology and treatment of depression, Future Neurology 2(2): 121-124, 2007.

Fisher, P.M., Meltzer, C.C., Ziolko, S.K., Price, J.C. and Hariri, A.R. Capacity for 5-HT1A mediated autoregulation predicts amygdala reactivity. Nature Neuroscience, 9(11): 1362-1363, 2006.